CX3CL1 and neoplasm: CX3CL1 encodes a secreted protein called fractalkine that recruits CX3CR1-expressing natural killer and T lymphocytes to the tumor microenvironment, thereby promoting natural killer-dependent antitumor responses in vivo[31].